Bend Bioscience Industry Insights

  1. Leveraging Integrated Electronic Laboratory Notebook And Inventory Systems 6/15/2026

    Integrating lab notebooks with inventory and asset tracking boosts accuracy and traceability. Real-time visibility cuts errors, speeds decisions, and supports compliant, scalable pharma development.

  2. Why CDMO Performance Drops Exactly When It Matters Most 6/15/2026

    Programs often stall moving to GMP due to fragmented workflows and knowledge gaps. Aligning teams and integrating development with execution, via continuous data, sustains momentum and reduces risk.

  3. Gaining A Competitive Edge Through Regulatory Compliance Confidence 12/10/2025

    Achieving regulatory compliance confidence is paramount for safety and competitive advantage. Adherence to standards and robust risk mitigation are essential to avoid delays and detrimental outcomes.

  4. Science To Success: CMC Strategies That Drive Market Readiness 12/10/2025

    Learn how a scientifically grounded framework for early-phase CMC development, integrating QbD and proactive risk management, helps de-risk drug development and accelerate the journey from molecule to market.

  5. API In Capsule Vs. The Lost Art Of Formulation Development 11/5/2025

    API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.

  6. Small Molecule Oral Delivery For Rare Diseases: Complexities As A CDMO 10/16/2025

    Developing therapies for rare diseases faces hurdles like high costs, small patient populations, and complex small-batch manufacturing. CDMOs offer crucial support, expertise, and flexibility.

  7. Spray Dried Dispersions In Controlled Release Formulations 10/16/2025

    Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.

  8. Strategic Approaches To Controlled Release Formulation: Polymer Screening And Case Study Insights 9/4/2025

    Discover how early polymer selection drives formulation success, with case studies linking polymer choice to drug release and practical insights for developing robust CR products.

  9. Site Transfer Of Tablet Production From Ex-U.S. To Georgia Site 6/11/2025

    Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

  10. Modifying The Micro-Environment To Improve Dissolution Rate 6/11/2025

    Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.